prospective observational cohort study to explore the relationship between PGE2 metabolite levels and the development of hemodynamically significant PDA in preterm neonates.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Explore the relationship between PGE2 metabolite levels and the development of hemodynamically significant PDA in preterm neonates.
Timeframe: initial PGE2 level on the first day of life and follow up the level after 3 days of treatment